ClinicalTrials.Veeva

Menu

Study to Prevent Negative Thoughts of Life

I

Institute for Research & Development Sri Lanka

Status

Unknown

Conditions

Active Suicidal Ideations

Treatments

Behavioral: Cognitive behavioural therapy
Other: Treatment as usual

Study type

Interventional

Funder types

Other

Identifiers

NCT00862732
IRD/03-08

Details and patient eligibility

About

The purpose of the study is to test whether cognitive behaviour therapy (CBT) offered by trained therapists, to people with current active suicidal ideations, is efficacious as a secondary prevention strategy in Sri Lanka, when compared with treatment as usual provided by Medical Officers (Mental Health; MO (MH)) of government hospitals

Enrollment

68 estimated patients

Sex

All

Ages

18 to 64 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age between 18 - 64 years
  • Self reported current active suicidal ideations
  • Ability to speak and write Sinhala

Exclusion criteria

  • An acute intent and planning of suicide
  • In-patient/out-patient treatment following an attempted suicide during the previous two-year period
  • A diagnosis of mental retardation
  • A diagnosis of sensory deficit
  • A diagnosis of alcohol abuse
  • A diagnosis of psychotic illness

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

68 participants in 2 patient groups

1 Cognitive Behavioural Therapy
Active Comparator group
Description:
Intervention group will receive a series of sessions of cognitive behaviour therapy. Delivery of CBT will be by three therapists; PI and two other Medical Officers. Each session will last for 30- 45 minutes and they will be delivered at the participant's residence (or at an alternative place of participant's choice) at two weeks intervals. They will be followed-up for three months from the cessation of CBT sessions.
Treatment:
Behavioral: Cognitive behavioural therapy
2 Treatment as usual
Active Comparator group
Description:
Will be referred to the MO(MH). They also will be followed-up for an equal length of time period as of the participants in the intervention group.
Treatment:
Other: Treatment as usual

Trial contacts and locations

1

Loading...

Central trial contact

Sudath Samaraweera, MBBS MSc MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems